Treatment of children and adolescents with tics and Tourette syndrome

被引:47
作者
Gilbert, Donald [1 ]
机构
[1] Childrens Hosp, Med Ctr, Movement Disorders Clin, Cincinnati, OH 45229 USA
[2] Childrens Hosp, Med Ctr, Tourette Syndrome Clin, Cincinnati, OH 45229 USA
关键词
D O I
10.1177/08830738060210080401
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Ties, patterned movements distinct from stereotypies, myoclonus, and other hyperldnetic movements, are quite common in children, particularly among those with developmental and psychiatric disorders. Thus, tics can indicate the presence of atypical neurodevelopment or broader difficulties with cognition or mood. Ties are also the cardinal feature of Tourette syndrome, a childhood-onset neurobehavioral disorder characterized by a chrortic inability to suppress or an urge to perform patterned, repetitive movements. Patients with Tourette syndrome most commonly have, in addition to tics, symptoms of inattention, hyperactivity, obsessiveness, or anxiety. Achieving the most effective treatment of a child with tics is contingent on proper diagnosis of the movement disorder and thorough assessment for other problems, followed by consideration of both noripharmacologic and pharmacologic interventions for any and all symptoms interfering with the child's function and quality of life. This review focuses primarily on the diagnosis and medical treatment of tics in children and adolescents with Tourette syndrome.
引用
收藏
页码:690 / 700
页数:11
相关论文
共 71 条
  • [41] STIMULANT MEDICATIONS PRECIPITATE TOURETTES SYNDROME
    LOWE, TL
    COHEN, DJ
    DETLOR, J
    KREMENITZER, MW
    SHAYWITZ, BA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 247 (12): : 1729 - 1731
  • [42] Repetitive arm and hand movements (complex motor stereotypies) in children
    Mahone, EM
    Bridges, D
    Prahme, C
    Singer, HS
    [J]. JOURNAL OF PEDIATRICS, 2004, 145 (03) : 391 - 395
  • [43] Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: A randomized, placebo-controlled study
    Michelson, D
    Allen, AJ
    Busner, J
    Casat, C
    Dunn, D
    Kratochvil, C
    Newcorn, J
    Sallee, FR
    Sangal, RB
    Saylor, K
    West, S
    Kelsey, D
    Wernicke, J
    Trapp, NJ
    Harder, D
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (11) : 1896 - 1901
  • [44] Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled, dose-response study
    Michelson, D
    Faries, D
    Wernicke, J
    Kelsey, D
    Kendrick, K
    Sallee, FR
    Spencer, T
    [J]. PEDIATRICS, 2001, 108 (05) : E83
  • [45] PSYCHIATRIC-SYMPTOMS DURING L-DOPA THERAPY FOR PARKINSONS-DISEASE AND THEIR RELATIONSHIP TO PHYSICAL-DISABILITY
    MINDHAM, RHS
    MARSDEN, CD
    PARKES, JD
    [J]. PSYCHOLOGICAL MEDICINE, 1976, 6 (01) : 23 - 33
  • [46] Basal ganglia dysfunction in Tourette's syndrome: A new hypothesis
    Mink, JW
    [J]. PEDIATRIC NEUROLOGY, 2001, 25 (03) : 190 - 198
  • [47] Myelopathy caused by tics in an adolescent, associated with T2 signal intensity changes of the spinal cord
    Muroi, A
    Matsumura, A
    Asakawa, H
    Enomoto, T
    Iwasaki, N
    Nose, T
    [J]. CHILDS NERVOUS SYSTEM, 2002, 18 (3-4) : 191 - 194
  • [48] A randomized, double-blind, placebo-controlled trial of metoclopramide for the treatment of Tourette's disorder
    Nicolson, R
    Craven-Thuss, B
    Smith, J
    McKinlay, BD
    Castellanos, FX
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2005, 44 (07) : 640 - 646
  • [49] Vascular cognitive impairment
    O'Brien, JT
    Erkinjuntti, T
    Reisberg, B
    Roman, G
    Sawada, T
    Pantoni, L
    Bowler, JV
    Ballard, C
    DeCarli, C
    Gorelick, PB
    Rockwood, K
    Burns, A
    Gauthier, S
    DeKosky, ST
    [J]. LANCET NEUROLOGY, 2003, 2 (02) : 89 - 98
  • [50] Depression in multiple sclerosis
    Patten, SB
    Metz, LM
    [J]. PSYCHOTHERAPY AND PSYCHOSOMATICS, 1997, 66 (06) : 286 - 292